Shares of Upexi, Inc. (NASDAQ:UPXI - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $7.83, but opened at $7.00. Upexi shares last traded at $7.74, with a volume of 4,221,558 shares traded.
Analyst Ratings Changes
A number of research analysts recently issued reports on the stock. Cantor Fitzgerald upgraded shares of Upexi to a "strong-buy" rating in a research note on Wednesday, August 13th. Wall Street Zen raised shares of Upexi to a "hold" rating in a research report on Friday, May 30th. Finally, Alliance Global Partners initiated coverage on shares of Upexi in a research note on Monday, August 4th. They set a "buy" rating and a $15.00 target price for the company. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Strong Buy" and an average price target of $15.50.
Check Out Our Latest Stock Analysis on UPXI
Upexi Stock Performance
The firm has a fifty day simple moving average of $6.31 and a 200-day simple moving average of $6.20. The company has a current ratio of 0.37, a quick ratio of 0.24 and a debt-to-equity ratio of 0.31.
Upexi (NASDAQ:UPXI - Get Free Report) last announced its earnings results on Friday, May 16th. The company reported ($2.87) earnings per share (EPS) for the quarter. The firm had revenue of $3.16 million during the quarter. Upexi had a negative net margin of 135.86% and a negative return on equity of 535.19%.
Insider Activity at Upexi
In other Upexi news, CEO Allan Marshall purchased 161,943 shares of Upexi stock in a transaction that occurred on Friday, July 11th. The stock was purchased at an average price of $4.94 per share, for a total transaction of $799,998.42. Following the transaction, the chief executive officer directly owned 1,046,261 shares in the company, valued at $5,168,529.34. This trade represents a 18.31% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Lawrence Dugan acquired 4,000 shares of the stock in a transaction on Tuesday, July 22nd. The shares were acquired at an average cost of $7.50 per share, for a total transaction of $30,000.00. Following the completion of the transaction, the director directly owned 116,389 shares in the company, valued at $872,917.50. The trade was a 3.56% increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 198,186 shares of company stock worth $997,759 in the last 90 days. 4.42% of the stock is owned by insiders.
Institutional Trading of Upexi
Hedge funds have recently added to or reduced their stakes in the stock. Bank of Montreal Can acquired a new stake in shares of Upexi during the fourth quarter worth $36,000. North Star Investment Management Corp. purchased a new position in Upexi during the 2nd quarter worth $45,000. Millington Financial Advisors LLC acquired a new stake in shares of Upexi in the 2nd quarter worth $60,000. XTX Topco Ltd purchased a new stake in shares of Upexi in the second quarter valued at about $249,000. Finally, Geode Capital Management LLC acquired a new position in shares of Upexi during the second quarter worth about $1,002,000. 5.68% of the stock is owned by institutional investors and hedge funds.
About Upexi
(
Get Free Report)
Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
Read More
Before you consider Upexi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Upexi wasn't on the list.
While Upexi currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.